Annual Net Income:
-$278.16M+$162.09M(+36.82%)Summary
- As of today, ALNY annual net profit is -$278.16 million, with the most recent change of +$162.09 million (+36.82%) on December 31, 2024.
- During the last 3 years, ALNY annual net income has risen by +$574.67 million (+67.38%).
- ALNY annual net income is now -6625.27% below its all-time high of -$4.14 million, reached on December 31, 2002.
Performance
ALNY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$66.28M-$8.80M(-15.31%)Summary
- As of today, ALNY quarterly net profit is -$66.28 million, with the most recent change of -$8.80 million (-15.31%) on June 30, 2025.
- Over the past year, ALNY quarterly net income has dropped by -$49.39 million (-292.43%).
- ALNY quarterly net income is now -144.86% below its all-time high of $147.75 million, reached on September 30, 2023.
Performance
ALNY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$319.09M-$49.39M(-18.31%)Summary
- As of today, ALNY TTM net profit is -$319.09 million, with the most recent change of -$49.39 million (-18.31%) on June 30, 2025.
- Over the past year, ALNY TTM net income has dropped by -$246.15 million (-337.46%).
- ALNY TTM net income is now -14734.45% below its all-time high of -$2.15 million, reached on March 31, 2003.
Performance
ALNY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ALNY Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +36.8% | -292.4% | -337.5% |
| 3Y3 Years | +67.4% | +76.1% | +67.5% |
| 5Y5 Years | +68.6% | +63.0% | +64.2% |
ALNY Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +75.4% | -144.9% | +83.7% | -337.5% | +73.0% |
| 5Y | 5-Year | at high | +75.4% | -144.9% | +83.7% | -337.5% | +73.0% |
| All-Time | All-Time | -6625.3% | +75.4% | -144.9% | +83.7% | >-9999.0% | +73.0% |
ALNY Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$66.28M(-15.3%) | -$319.09M(-18.3%) |
| Mar 2025 | - | -$57.48M(+31.4%) | -$269.70M(+3.0%) |
| Dec 2024 | -$278.16M(+36.8%) | -$83.76M(+24.9%) | -$278.16M(+16.3%) |
| Sep 2024 | - | -$111.57M(-560.6%) | -$332.26M(-355.5%) |
| Jun 2024 | - | -$16.89M(+74.4%) | -$72.94M(+78.0%) |
| Mar 2024 | - | -$65.94M(+52.2%) | -$332.08M(+24.6%) |
| Dec 2023 | -$440.24M(+61.1%) | -$137.87M(-193.3%) | -$440.24M(+13.7%) |
| Sep 2023 | - | $147.75M(+153.5%) | -$509.87M(+52.1%) |
| Jun 2023 | - | -$276.02M(-58.5%) | -$1.06B(+0.1%) |
| Mar 2023 | - | -$174.10M(+16.1%) | -$1.06B(+5.9%) |
| Dec 2022 | -$1.13B(-32.6%) | -$207.49M(+48.9%) | -$1.13B(+4.3%) |
| Sep 2022 | - | -$405.92M(-46.3%) | -$1.18B(-20.5%) |
| Jun 2022 | - | -$277.40M(-15.4%) | -$980.72M(-9.8%) |
| Mar 2022 | - | -$240.34M(+7.0%) | -$892.87M(-4.7%) |
| Dec 2021 | -$852.82M(+0.6%) | -$258.46M(-26.4%) | -$852.82M(-1.8%) |
| Sep 2021 | - | -$204.51M(-7.9%) | -$837.90M(+5.5%) |
| Jun 2021 | - | -$189.56M(+5.4%) | -$886.68M(-1.2%) |
| Mar 2021 | - | -$200.29M(+17.8%) | -$876.35M(-2.1%) |
| Dec 2020 | -$858.28M(+3.1%) | -$243.54M(+3.8%) | -$858.28M(+3.7%) |
| Sep 2020 | - | -$253.29M(-41.3%) | -$890.93M(-5.3%) |
| Jun 2020 | - | -$179.23M(+1.6%) | -$846.17M(+4.5%) |
| Mar 2020 | - | -$182.22M(+34.0%) | -$886.42M(-0.0%) |
| Dec 2019 | -$886.12M(-16.4%) | -$276.19M(-32.4%) | -$886.12M(-7.9%) |
| Sep 2019 | - | -$208.53M(+5.0%) | -$821.37M(+4.3%) |
| Jun 2019 | - | -$219.48M(-20.7%) | -$858.12M(-7.0%) |
| Mar 2019 | - | -$181.91M(+14.0%) | -$802.20M(-5.3%) |
| Dec 2018 | -$761.50M(-55.1%) | -$211.44M(+13.8%) | -$761.50M(-10.0%) |
| Sep 2018 | - | -$245.28M(-50.0%) | -$692.28M(-21.5%) |
| Jun 2018 | - | -$163.56M(-15.8%) | -$569.94M(-8.6%) |
| Mar 2018 | - | -$141.21M(+0.7%) | -$524.80M(-6.9%) |
| Dec 2017 | -$490.87M(-19.7%) | -$142.23M(-15.7%) | -$490.87M(-6.3%) |
| Sep 2017 | - | -$122.94M(-3.8%) | -$461.58M(-4.3%) |
| Jun 2017 | - | -$118.42M(-10.4%) | -$442.71M(-6.8%) |
| Mar 2017 | - | -$107.29M(+5.0%) | -$414.42M(-1.1%) |
| Dec 2016 | -$410.11M(-41.4%) | -$112.93M(-8.5%) | -$410.11M(-5.7%) |
| Sep 2016 | - | -$104.07M(-15.5%) | -$387.89M(-7.6%) |
| Jun 2016 | - | -$90.13M(+12.5%) | -$360.62M(-5.4%) |
| Mar 2016 | - | -$102.97M(-13.5%) | -$342.27M(-18.0%) |
| Dec 2015 | -$290.07M(+19.5%) | -$90.72M(-18.1%) | -$290.07M(-31.4%) |
| Sep 2015 | - | -$76.79M(-7.0%) | -$220.74M(-17.5%) |
| Jun 2015 | - | -$71.78M(-41.4%) | -$187.94M(-17.3%) |
| Mar 2015 | - | -$50.78M(-137.4%) | -$160.23M(+55.5%) |
| Dec 2014 | -$360.39M | -$21.39M(+51.4%) | -$360.39M(+3.0%) |
| Sep 2014 | - | -$43.99M(+0.2%) | -$371.36M(-4.0%) |
| Jun 2014 | - | -$44.07M(+82.4%) | -$357.06M(-7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$250.94M(-675.5%) | -$331.15M(-271.1%) |
| Dec 2013 | -$89.22M(+15.8%) | -$32.36M(-9.0%) | -$89.22M(+25.1%) |
| Sep 2013 | - | -$29.69M(-63.4%) | -$119.06M(-9.4%) |
| Jun 2013 | - | -$18.17M(-101.6%) | -$108.87M(-5.0%) |
| Mar 2013 | - | -$9.01M(+85.5%) | -$103.66M(+2.2%) |
| Dec 2012 | -$106.01M(-83.9%) | -$62.19M(-218.9%) | -$106.01M(-82.4%) |
| Sep 2012 | - | -$19.50M(-50.5%) | -$58.13M(-12.1%) |
| Jun 2012 | - | -$12.96M(-14.0%) | -$51.86M(+1.6%) |
| Mar 2012 | - | -$11.37M(+20.5%) | -$52.73M(+8.5%) |
| Dec 2011 | -$57.65M(-32.5%) | -$14.30M(-8.1%) | -$57.65M(-14.7%) |
| Sep 2011 | - | -$13.24M(+4.2%) | -$50.28M(-7.7%) |
| Jun 2011 | - | -$13.82M(+15.1%) | -$46.67M(+1.7%) |
| Mar 2011 | - | -$16.29M(-135.0%) | -$47.48M(-9.1%) |
| Dec 2010 | -$43.52M(+8.6%) | -$6.93M(+28.0%) | -$43.52M(+1.9%) |
| Sep 2010 | - | -$9.63M(+34.2%) | -$44.38M(-1.0%) |
| Jun 2010 | - | -$14.63M(-18.7%) | -$43.95M(+15.5%) |
| Mar 2010 | - | -$12.32M(-58.2%) | -$52.02M(-9.3%) |
| Dec 2009 | -$47.59M(-81.3%) | -$7.79M(+15.4%) | -$47.59M(+3.3%) |
| Sep 2009 | - | -$9.21M(+59.4%) | -$49.19M(-14.8%) |
| Jun 2009 | - | -$22.70M(-187.8%) | -$42.84M(-30.2%) |
| Mar 2009 | - | -$7.89M(+16.0%) | -$32.90M(-25.3%) |
| Dec 2008 | -$26.25M(+69.3%) | -$9.39M(-228.6%) | -$26.25M(-72.7%) |
| Sep 2008 | - | -$2.86M(+77.6%) | -$15.20M(+76.7%) |
| Jun 2008 | - | -$12.76M(-929.9%) | -$65.13M(-0.1%) |
| Mar 2008 | - | -$1.24M(-174.5%) | -$65.06M(+23.9%) |
| Dec 2007 | -$85.47M(-147.0%) | $1.66M(+103.1%) | -$85.47M(+10.6%) |
| Sep 2007 | - | -$52.79M(-316.0%) | -$95.57M(-90.5%) |
| Jun 2007 | - | -$12.69M(+41.4%) | -$50.17M(-5.9%) |
| Mar 2007 | - | -$21.64M(-156.5%) | -$47.39M(-36.9%) |
| Dec 2006 | -$34.61M(+19.4%) | -$8.44M(-14.0%) | -$34.61M(+14.9%) |
| Sep 2006 | - | -$7.40M(+25.3%) | -$40.66M(+7.5%) |
| Jun 2006 | - | -$9.91M(-11.9%) | -$43.94M(+2.7%) |
| Mar 2006 | - | -$8.86M(+38.9%) | -$45.17M(-5.3%) |
| Dec 2005 | -$42.91M(-21.3%) | -$14.49M(-35.7%) | -$42.91M(-25.8%) |
| Sep 2005 | - | -$10.68M(+4.2%) | -$34.12M(-14.3%) |
| Jun 2005 | - | -$11.14M(-68.9%) | -$29.86M(-13.0%) |
| Mar 2005 | - | -$6.60M(-15.8%) | -$26.42M(+25.3%) |
| Dec 2004 | -$35.37M(-26.6%) | -$5.70M(+11.2%) | -$35.37M(+1.6%) |
| Sep 2004 | - | -$6.42M(+16.8%) | -$35.92M(-0.4%) |
| Jun 2004 | - | -$7.71M(+50.4%) | -$35.77M(-14.3%) |
| Mar 2004 | - | -$15.54M(-148.4%) | -$31.30M(-74.8%) |
| Dec 2003 | -$27.94M(-575.5%) | -$6.26M(0.0%) | -$17.91M(-53.7%) |
| Sep 2003 | - | -$6.26M(-92.9%) | -$11.65M(-116.0%) |
| Jun 2003 | - | -$3.24M(-50.8%) | -$5.39M(-150.8%) |
| Mar 2003 | - | -$2.15M | -$2.15M |
| Dec 2002 | -$4.14M | - | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual net profit?
The current annual net income of ALNY is -$278.16M
What is the all-time high annual net income for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual net profit is -$4.14M
What is Alnylam Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, ALNY annual net profit has changed by +$162.09M (+36.82%)
What is Alnylam Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of ALNY is -$66.28M
What is the all-time high quarterly net income for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly net profit is $147.75M
What is Alnylam Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, ALNY quarterly net profit has changed by -$49.39M (-292.43%)
What is Alnylam Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of ALNY is -$319.09M
What is the all-time high TTM net income for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high TTM net profit is -$2.15M
What is Alnylam Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, ALNY TTM net profit has changed by -$246.15M (-337.46%)